inner-banner-bg

Advances in Bioengineering and Biomedical Science Research(ABBSR)

ISSN: 2640-4133 | DOI: 10.33140/ABBSR

Impact Factor: 1.7

Hyperinsulinism Gateway Between Diabetes and Cancer: New Roles for Bifunctional Antidiabetic-Anticancer Active Somatostatins, IGF-1 Inhibitors and Insulin Sensitizers

Citation

Ofodire Emeka

Ofodire, E. (2023). Hyperinsulinism Gateway Between Diabetes and Cancer: New Roles for Bifunctional Antidiabetic - Anticancer Active Somatostatins, IGF - 1 Inhibitors and Insulin Sensitizers. Adv Bioeng Biomed Sci Res, 6(3), 17-24.

Abstract PDF